Study Comparing One Versus Two Cortisone Injections for Trigger Finger
NCT ID: NCT00951236
Last Updated: 2014-02-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
392 participants
INTERVENTIONAL
2009-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Trigger Finger With Steroid Injection Versus Steroid Injection and Splinting
NCT01886157
Trigger Finger Corticosteroid Injection With and Without Local Anesthetic
NCT04023695
Effectiveness of Cortisone Injection and Splinting for Trigger Finger
NCT03156829
Long Term Effectiveness of Trigger Finger Injections With Triamcinolone vs. Dexamethasone
NCT03641508
The TriggerHappy Trial
NCT04568993
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PARALLEL
TREATMENT
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
One injection
One cortisone injection
Patients in this arm will receive one cortisone injection for the treatment of his/her symptoms
Two Injections
Two cortisone Injections
Subjects randomized to this treatment will receive two cortisone injections, 4-6 weeks apart
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
One cortisone injection
Patients in this arm will receive one cortisone injection for the treatment of his/her symptoms
Two cortisone Injections
Subjects randomized to this treatment will receive two cortisone injections, 4-6 weeks apart
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is willing and able to provide informed consent.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rothman Institute Orthopaedics
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rothman Institute
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Charles Leinberry, MD
Role: PRINCIPAL_INVESTIGATOR
Rothman Institute
Pedro Beredjiklian, MD
Role: PRINCIPAL_INVESTIGATOR
Rothman Institute
Emran Sheikh, MD
Role: PRINCIPAL_INVESTIGATOR
Rothman Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rothman Institute: Egg Harbor Township Location
Egg Harbor, New Jersey, United States
Rothman Institute: Manahawkin location
Manahawkin, New Jersey, United States
Rothman Institute: Vorhees location
Vorhees, New Jersey, United States
Rothman Institute: Media location
Media, Pennsylvania, United States
Rothman Institute Center City Location
Philadelphia, Pennsylvania, United States
Rothman Institute, South Philadelphia Location
Philadelphia, Pennsylvania, United States
Rothman Institute, Northeast Philadelphia location
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RIUCLEI 09-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.